<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="RepMMWR Morb. Mortal. Wkly. RepWRMorbidity and Mortality Weekly Report0149-21951545-861XCenters for" exact="Disease" post="Control and Prevention pmcid: 7238951 pmid: 32407307mm6919a1 doi: 10.15585/mmwr.mm6919a1"/>
 <result pre="pmid: 32407307mm6919a1 doi: 10.15585/mmwr.mm6919a1 : Full Report High Prevalence of" exact="Hepatitis" post="C Infection Among Adult Patients at Four Urban Emergency"/>
 <result pre="doi: 10.15585/mmwr.mm6919a1 : Full Report High Prevalence of Hepatitis C" exact="Infection" post="Among Adult Patients at Four Urban Emergency Departments â€&quot;"/>
 <result pre=": Full Report High Prevalence of Hepatitis C Infection Among" exact="Adult" post="Patients at Four Urban Emergency Departments â€&quot; Birmingham, Oakland,"/>
 <result pre="citation as to source, however, is appreciated. Identifying persons with" exact="hepatitis C" post="virus (HCV) infection has become an urgent public health"/>
 <result pre="however, is appreciated. Identifying persons with hepatitis C virus (HCV)" exact="infection" post="has become an urgent public health challenge because of"/>
 <result pre="all persons born during 1945â€&quot;1965 (baby boomers) for identification of" exact="chronic" post="HCV infection (1); urban emergency departments (EDs) are well"/>
 <result pre="born during 1945â€&quot;1965 (baby boomers) for identification of chronic HCV" exact="infection" post="(1); urban emergency departments (EDs) are well positioned venues"/>
 <result pre="emergency departments (EDs) are well positioned venues for detecting HCV" exact="infection" post="among these persons. The United States has witnessed an"/>
 <result pre="drug use behavior has led to an increase in HCV" exact="infections" post="among persons who inject drugs and heightened concern about"/>
 <result pre="who inject drugs and heightened concern about increases in human" exact="immunodeficiency" post="virus (HIV) and HCV infection within communities disproportionately affected"/>
 <result pre="concern about increases in human immunodeficiency virus (HIV) and HCV" exact="infection" post="within communities disproportionately affected by the opioid crisis (3,4)."/>
 <result pre="the opioid crisis (3,4). However, targeted strategies for identifying HCV" exact="infection" post="among persons who inject drugs is challenging (5,6). During"/>
 <result pre="(i.e., patients can implicitly accept or explicitly decline testing), universal" exact="hepatitis C" post="screening for all adult patients. ED staff members offered"/>
 <result pre="or explicitly decline testing), universal hepatitis C screening for all" exact="adult" post="patients. ED staff members offered HCV antibody (anti-HCV) screening"/>
 <result pre="overall 9.2% prevalence of positive results for anti-HCV among the" exact="adult" post="patient population. Among the 1945â€&quot;1965 birth cohort, prevalence of"/>
 <result pre="ED venues and opt-out, universal testing strategies to improve HCV" exact="infection" post="awareness and surveillance for hard-to-reach populations. This opt-out, universal"/>
 <result pre="opt-out, universal testing approach is supported by new recommendations for" exact="hepatitis C" post="screening at least once in a lifetime for all"/>
 <result pre="in settings where the prevalence of positive results for HCV" exact="infection" post="is &amp;lt;0.1% (7). A retrospective study from four urban"/>
 <result pre="institutionâ€™s local Institutional Review Board. Each ED implemented opt-out, universal" exact="hepatitis C" post="testing at different times and using differing methodologies among"/>
 <result pre="months, starting 1 month after initial implementation of opt-out, universal" exact="hepatitis C" post="screening. Because of programmatic changes during the observation period"/>
 <result pre="to deliver positive test results and facilitate referral to HCV" exact="infection" post="care. ED sites collected cumulative hepatitis C testing outcomes"/>
 <result pre="facilitate referral to HCV infection care. ED sites collected cumulative" exact="hepatitis C" post="testing outcomes for the 4-month study period, including cumulative"/>
 <result pre="was used to conduct all statistical analyses. Using opt-out, universal" exact="hepatitis C" post="screening (Table 1), EDs performed a total of 14,252"/>
 <result pre="opt-out, universal hepatitis C screening (Table 1), EDs performed a" exact="total" post="of 14,252 tests on unique visitors, and 1,315 (9.2%)"/>
 <result pre="results for anti-HCV (Table 2). HCV RNA testing for current" exact="infection" post="was performed for 1,118 (85%) visitors with positive test"/>
 <result pre="the younger cohort accounted for 47.8% (628 of 1,315) of" exact="total" post="cases reactive to anti-HCV identified. TABLE 1 Universal hepatitis"/>
 <result pre="of total cases reactive to anti-HCV identified. TABLE 1 Universal" exact="hepatitis C" post="testing programs at four urban emergency departments (EDs) â€&quot;"/>
 <result pre="=Â HCV antibody; EHRÂ =Â electronic health record; HCVÂ =Â" exact="hepatitis C" post="virus. * Limited to a 3-month testing period because"/>
 <result pre="=Â electronic health record; HCVÂ =Â hepatitis C virus. *" exact="Limited" post="to a 3-month testing period because of programmatic changes"/>
 <result pre="programmatic changes occurring during the observation period. TABLE 2 Universal" exact="hepatitis C" post="testing results at four urban emergency departments (EDs) â€&quot;"/>
 <result pre="ED visitors 18,916 18,272 13,069 26,870 77,127 Patients eligible for" exact="hepatitis C" post="testing 13,999 9,585 7,639 12,284 43,507â€ Anti-HCV tests performed"/>
 <result pre="12,284 43,507â€ Anti-HCV tests performed 5,973 2,900 1,638 3,741 14,252Â§" exact="Total" post="anti-HCV positive tests (%) 459 (7.7) 166 (5.7) 120"/>
 <result pre="227/3,768 (6.0) 68/2,187 (3.1) 51/1,201 (4.2%) 282/2,156 (13.1) 628/9,312 (6.7)" exact="Total" post="HCV RNA tests performed (%) 398 (86.9) 125 (75.3)"/>
 <result pre="398 (86.9) 125 (75.3) 38 (31.6) 557 (97.7) 1,118 (85)" exact="Total" post="current HCV infections (positive test results for HCV RNA)"/>
 <result pre="(75.3) 38 (31.6) 557 (97.7) 1,118 (85) Total current HCV" exact="infections" post="(positive test results for HCV RNA) (%) 252 (63.3)"/>
 <result pre="=Â HCV antibody; EHRÂ =Â electronic health record; HCVÂ =Â" exact="hepatitis C" post="virus. * Limited to a 3-month testing period because"/>
 <result pre="=Â electronic health record; HCVÂ =Â hepatitis C virus. *" exact="Limited" post="to a 3-month testing period because of programmatic changes"/>
 <result pre="Highland Hospital (3.2%). TABLE 3 Prevalence of positive results for" exact="hepatitis C" post="virus antibody (anti-HCV) and prevalence differences, by study site"/>
 <result pre="Hopkins Hospital, Baltimore, Maryland Boston University Medical Center, Boston, Massachusetts" exact="Total" post="no. (% positive test results for anti-HCV) Prevalence difference"/>
 <result pre="(% positive test results for anti-HCV) Prevalence difference (95% CI)*" exact="Total" post="no. (% positive test results for anti-HCV) Prevalence difference"/>
 <result pre="(% positive test results for anti-HCV) Prevalence difference (95% CI)*" exact="Total" post="no. (% positive test results for anti-HCV) Prevalence difference"/>
 <result pre="(% positive test results for anti-HCV) Prevalence difference (95% CI)*" exact="Total" post="no. (% positive test results for anti-HCV) Prevalence difference"/>
 <result pre="(% positive test results for anti-HCV) Prevalence difference (95% CI)*" exact="Total" post="no. (% positive test results for anti-HCV) Prevalence difference"/>
 <result pre="results for anti-HCV in approximately one of every 11 (9.2%)" exact="adult" post="patients tested. Prevalence of positive results for HCV RNA"/>
 <result pre="advent of HCV curative therapies, potential exists to eliminate HCV" exact="infection" post="from U.S. communities. For this reason, identification of persons"/>
 <result pre="For this reason, identification of persons unaware of their HCV" exact="infection" post="has become a public health priority. Because of the"/>
 <result pre="public health priority. Because of the increasing incidence of HCV" exact="infection" post="among persons who inject drugs, testing and treatment of"/>
 <result pre="testing and treatment of this population is needed for both" exact="infection" post="prevention and for ending the HCV infection epidemic. Although"/>
 <result pre="needed for both infection prevention and for ending the HCV" exact="infection" post="epidemic. Although recent studies of ED-based, targeted hepatitis C"/>
 <result pre="the HCV infection epidemic. Although recent studies of ED-based, targeted" exact="hepatitis C" post="testing have highlighted the high prevalence of positive results"/>
 <result pre="persons who inject drugs (5,6,9,10). Although three quarters of HCV" exact="infections" post="in the United States are among persons born during"/>
 <result pre="alone would fail to identify half of persons with HCV" exact="infection" post="(8,9). Most striking in the current study was the"/>
 <result pre="this racial/ethnic difference is consistent with the epidemiology of HCV" exact="infection" post="and injection drug use behavior (2). By leveraging lessons"/>
 <result pre="testing efforts, opt-out, universal HCV screening might improve rates of" exact="hepatitis C" post="testing among populations at high risk by reducing patient"/>
 <result pre="by reducing patient and provider stigma associated with identification of" exact="hepatitis C" post="behavioral risks as a prerequisite for testing. In addition,"/>
 <result pre="by competing priorities. Although both targeted and opt-out, universal ED-based" exact="hepatitis C" post="testing strategies are effective at identifying previously unrecognized HCV"/>
 <result pre="previously unrecognized HCV infections, reimbursement for testing and challenging HCV" exact="infection" post="care navigation remain crucial barriers. A 2014 decision from"/>
 <result pre="for Medicare &amp;amp; Medicaid Services precluding EDs from reimbursement for" exact="hepatitis C" post="testing might be limiting adoption of any systematic hepatitis"/>
 <result pre="hepatitis C testing might be limiting adoption of any systematic" exact="hepatitis C" post="testing in the majority of EDs.â€ In addition, the"/>
 <result pre="EDs.â€ In addition, the high number of persons with HCV" exact="infection" post="identified in the ED setting challenges HCV navigation programs"/>
 <result pre="positive to HCV treatment and other necessary health services, including" exact="primary" post="care, social services, and substance use treatment. The findings"/>
 <result pre="to at least three limitations. First, identifying previously unrecognized HCV" exact="infection" post="is limited by the patientâ€™s recall of their prior"/>
 <result pre="least three limitations. First, identifying previously unrecognized HCV infection is" exact="limited" post="by the patientâ€™s recall of their prior HCV infection"/>
 <result pre="is limited by the patientâ€™s recall of their prior HCV" exact="infection" post="history and is therefore subject to bias. Second, 29,255"/>
 <result pre="to bias. Second, 29,255 persons identified as being eligible for" exact="hepatitis C" post="testing in the study EDs were not tested because"/>
 <result pre="This is consistent with previously reported findings from ED-based targeted" exact="hepatitis C" post="testing (5,6), and bias was not introduced toward testing"/>
 <result pre="appearing to be at high risk. Finally, study findings are" exact="limited" post="to four geographically diverse, urban academic EDs, and might"/>
 <result pre="in nonurban or community EDs. The high prevalence of HCV" exact="infection" post="identified among persons born after 1965 as well as"/>
 <result pre="as those born during 1945â€&quot;1965 supports continued assessment of ED-based" exact="hepatitis C" post="testing, as well as an opt-out, universal screening strategy"/>
 <result pre="and combat of interrelated epidemics of opioid overdose and bloodborne" exact="viral" post="infections through harm-reduction interventions and navigation to HCV treatment."/>
 <result pre="combat of interrelated epidemics of opioid overdose and bloodborne viral" exact="infections" post="through harm-reduction interventions and navigation to HCV treatment. Summary"/>
 <result pre="What is already known about this topic? Targeted testing for" exact="hepatitis C" post="virus (HCV) infection in emergency departments (EDs) has been"/>
 <result pre="about this topic? Targeted testing for hepatitis C virus (HCV)" exact="infection" post="in emergency departments (EDs) has been demonstrated to be"/>
 <result pre="HCV screening in EDs identified that nearly half (47.5%) of" exact="infections" post="were among persons born after 1965. What are the"/>
 <result pre="infections, especially among persons born after 1965. ED-based opt-out, universal" exact="hepatitis C" post="screening can be vital in combating and surveilling the"/>
 <result pre="and surveilling the interrelated epidemics of opioid overdose and bloodborne" exact="viral" post="infections through harm-reduction interventions and navigation to HCV treatment."/>
 <result pre="surveilling the interrelated epidemics of opioid overdose and bloodborne viral" exact="infections" post="through harm-reduction interventions and navigation to HCV treatment. *To"/>
 <result pre="SmithBD, MorganRL, BeckettGA, et al.. Recommendations for the identification of" exact="chronic hepatitis C" post="virus infection among persons born during 1945â€&quot;1965.MMWR Recomm Rep2012;61(No."/>
 <result pre="MorganRL, BeckettGA, et al.. Recommendations for the identification of chronic" exact="hepatitis C" post="virus infection among persons born during 1945â€&quot;1965.MMWR Recomm Rep2012;61(No."/>
 <result pre="et al.. Recommendations for the identification of chronic hepatitis C" exact="virus infection" post="among persons born during 1945â€&quot;1965.MMWR Recomm Rep2012;61(No. RR-4).22895429 2."/>
 <result pre="al.. Recommendations for the identification of chronic hepatitis C virus" exact="infection" post="among persons born during 1945â€&quot;1965.MMWR Recomm Rep2012;61(No. RR-4).22895429 2."/>
 <result pre="Rep2018;67:1419â€&quot;27. 10.15585/mmwr.mm675152e130605448 3. SuryaprasadAG, WhiteJZ, XuF, et al.Emerging epidemic of" exact="hepatitis C" post="virus infections among young nonurban persons who inject drugs"/>
 <result pre="SuryaprasadAG, WhiteJZ, XuF, et al.Emerging epidemic of hepatitis C virus" exact="infections" post="among young nonurban persons who inject drugs in the"/>
 <result pre="al.County-level vulnerability assessment for rapid dissemination of HIV or HCV" exact="infections" post="among persons who inject drugs, United States.J Acquir Immune"/>
 <result pre="Immune Defic Syndr2016;73:323â€&quot;31. 10.1097/QAI.000000000000109827763996 5. GalbraithJW, FrancoRA, DonnellyJP, et al.Unrecognized" exact="chronic hepatitis C" post="virus infection among baby boomers in the emergency department.Hepatology2015;61:776â€&quot;82."/>
 <result pre="Defic Syndr2016;73:323â€&quot;31. 10.1097/QAI.000000000000109827763996 5. GalbraithJW, FrancoRA, DonnellyJP, et al.Unrecognized chronic" exact="hepatitis C" post="virus infection among baby boomers in the emergency department.Hepatology2015;61:776â€&quot;82."/>
 <result pre="10.1097/QAI.000000000000109827763996 5. GalbraithJW, FrancoRA, DonnellyJP, et al.Unrecognized chronic hepatitis C" exact="virus infection" post="among baby boomers in the emergency department.Hepatology2015;61:776â€&quot;82. 10.1002/hep.2741025179527 6."/>
 <result pre="5. GalbraithJW, FrancoRA, DonnellyJP, et al.Unrecognized chronic hepatitis C virus" exact="infection" post="among baby boomers in the emergency department.Hepatology2015;61:776â€&quot;82. 10.1002/hep.2741025179527 6."/>
 <result pre="6. WhiteDAE, AndersonES, PfeilSK, TrivediTK, AlterHJ. Results of a rapid" exact="hepatitis C" post="virus screening and diagnostic testing program in an urban"/>
 <result pre="10.1016/j.annemergmed.2015.06.02326253712 7. SchillieS, WesterC, OsborneM, WesolowskiL, RyersonAB. CDC recommendations for" exact="hepatitis C" post="screening among adultsâ€&quot;United States, 2020.MMWR Recomm Rep2020;69(No. RR-2). 10.15585/mmwr.rr6902a132271723"/>
 <result pre="Rep2020;69(No. RR-2). 10.15585/mmwr.rr6902a132271723 8. RosenbergES, RosenthalEM, HallEW, et al.Prevalence of" exact="hepatitis C" post="virus infection in US states and the District of"/>
 <result pre="10.15585/mmwr.rr6902a132271723 8. RosenbergES, RosenthalEM, HallEW, et al.Prevalence of hepatitis C" exact="virus infection" post="in US states and the District of Columbia, 2013"/>
 <result pre="8. RosenbergES, RosenthalEM, HallEW, et al.Prevalence of hepatitis C virus" exact="infection" post="in US states and the District of Columbia, 2013"/>
 <result pre="TaylorLE. HCV among The Miriam Hospital and Rhode Island Hospital" exact="adult" post="ED patients.R I Med J (2013)2014;97:35â€&quot;9.24983020 10. HsiehY-H, RothmanRE,"/>
 <result pre="10. HsiehY-H, RothmanRE, LaeyendeckerOB, et al.Evaluation of the Centers for" exact="Disease" post="Control and Prevention recommendations for hepatitis C virus testing"/>
 <result pre="of the Centers for Disease Control and Prevention recommendations for" exact="hepatitis C" post="virus testing in an urban emergency department.Clin Infect Dis2016;62:1059â€&quot;65."/>
</results>
